At the end of cardiopulmonary bypass, there are invariably several hundred millilitres of residual pump blood in the reservoir, which can either be re-transfused or discarded. The objective of this prospective observational study was to investigate the quality of the residual pump blood, focusing on plasma free haemoglobin (pfHb) and blood cell counts. Fifty-one consecutive patients were included in the study. Forty-nine units of residual pump blood and 58 units of transfused red blood cell (RBC) concentrates were analysed. The mean preoperative pfHb of the patients was 0.057 ± 0.062 g/l, which increased gradually to 0.55 ± 0.36 g/l on arrival in the intensive care unit postoperatively. On the first postoperative day, the mean pfHb had returned to within the normal range. Our data showed that haemoglobin, haematocrit, and erythrocyte counts of residual pump blood were approximately 40% of the values in standardised RBC concentrates. Plasma free haemoglobin was significantly higher in residual pump blood compared to RBC concentrates, and nearly twice as high as the pfHb in patient blood samples taken contemporaneously. Our findings indicate that residual pump blood pfHb levels are markedly higher compared to patients' blood and RBC concentrates, but that its administration does not significantly increase patients' pfHb levels.
Introduction
Cardiac surgery involving cardiopulmonary bypass (CPB) is one of the most frequent and standardised surgical procedures, with over two million cases performed worldwide each year 1 . In the last decade, several studies have been published showing an association between the transfusion of red blood cell (RBC) concentrates and increased morbidity, infection, and mortality [2] [3] [4] [5] [6] [7] . Thus, the trend is towards avoiding transfusion of RBC concentrates where possible, and patient blood management programs are currently being generated in several countries 8 . On the other hand, more deaths were recently reported using restrictive (haemoglobin [Hb] <75 g/l) rather than liberal (Hb <90 g/l) RBC transfusion after cardiac surgery 9 . In either context the re-transfusion of residual pump blood may play a role in raising Hb levels or avoiding RBC transfusion.
Cardiac surgery patients usually have preoperative Hb in the lower than normal range. In addition, the priming volume used in CPB circuits causes haemodilution. At the end of CPB, the reservoir and circuit usually contain several hundred millilitres of residual pump blood, which can be either re-transfused or discarded. Arguments against the re-transfusion of residual pump blood include its doubtful quality, due to haemolysis and the presence of inflammatory substances 1 . One problem that has not been fully investigated is the plasma free Hb (pfHb) levels in pump blood and its effect on patients' pfHB levels if the residual pump blood is re-transfused. The aim of this study was to measure the concentration of pfHb in residual pump blood transfused to patients to determine the pfHb load, and to investigate whether the re-transfusion of residual pump blood increases patient pfHb levels.
Materials and methods
The study protocol was approved by the local ethics committee of the Medical Faculty, University of Goettingen, Germany (registration no. 28/10/11), and informed patient consent was obtained. It was designed as a prospective observational study in a cohort of adult patients older than 18 years undergoing cardiac surgery involving CPB at the University Hospital of Goettingen. The study was conducted between January 2012 and May 2012.
Exclusion criteria
Patients who received extracorporeal membrane oxygenation pre-or postoperatively were excluded. Additionally, patients with known inherited coagulation disorders were excluded.
Intraoperative settings
A total of 51 patients undergoing isolated coronary artery bypass graft, valve, or combined procedures via median sternotomy involving CPB were included in the study. Before cannulation, unfractionated heparin (300 IU/kg body weight) was administered. In addition, the priming volume (1500 ml) of the heart-lung machine (Maquet Jostra HL20, SOMA Technology Inc., Bloomfield, CT, USA) included 7,500 IU of unfractionated heparin. Before instituting CPB, activated clotting time (ACT) was measured, and an additional dose of 5,000-7,500 IU of unfractionated heparin was administered if the ACT was less than 400 seconds. CPB was established in most cases with a centrifugal pump (43 patients) and a membrane oxygenator (Capiox® FX 25E/R, Terumo, Ann Arbor, MI, USA). In the remaining eight patients a roller pump was used. Body temperature (urinary bladder temperature) was kept between 32°C and 36°C. Myocardial protection was achieved with Buckberg blood cardioplegia solution. After termination of the CPB, unfractionated heparin was reversed by protamine chloride and the ACT was corrected at the end of the surgery. With the administration of protamine, blood aspiration into the CPB reservoir by the suckers was ceased. The blood circulated in the heart-lung machine until sternal closure. It was then drained into a bag and re-transfused before transfer to the intensive care unit (ICU). All patients received 2 g of tranexamic acid as hyperfibrinolysis prophylaxis within the CPB priming volume and again intravenously after separation from CPB. RBC concentrates, blood products and coagulation factors were administered on the basis of our standard operational procedures monitored by laboratory analyses and rotational thromboelastometry (ROTEM®, Tem Innovations GmbH, Munich, Germany). The Hb concentration was maintained at 80-100 g/l by transfusing RBC concentrates as required.
Postoperative fluid therapy consisted of a basic crystalloid infusion (80 ml/hour). Additional volumes of primarily crystalloid infusion were administered as necessary. Unfractionated heparin was started 24 hours postoperatively (10,000 IU/24 hours).
Data collection
A sample of one millilitre of the residual pump blood bag and of any RBC concentrate used was collected to measure pfHb as detailed below. In addition, Hb and haematocrit were analysed at our central laboratory. Patient preoperative baseline characteristics and perioperative laboratory results were recorded with a particular focus on pfHb, haemoglobin, and haematocrit. They were measured preoperatively just before anaesthesia induction, 15 minutes and 60 minutes after starting CPB, 15 minutes after protamine administration, upon ICU arrival, and on the first and second postoperative mornings at 0500 hours. Plasma free Hb was quantified with a 3-wavelength-measuring method (Photometer 5010 V5, Robert Riele KG, Berlin, Germany) intraoperatively, and once in the ICU, with a 7-wavelength-measuring method (ARCHITECT, Abbott Clinical Chemistry, Abbott Park, IL, USA).
Statistical analysis
Continuous variables are presented as the mean ± standard deviation (SD) or median (interquartile range, IQR: 25% percentile-75% percentile), and categorical variables are presented as numbers and percentages. The data were checked for normality before statistical analysis (D'Agostino and Pearson omnibus normality test, PRISM 5.02, GraphPad Software Inc., La Jolla, CA, USA). Continuous variables were compared using the Student's t-test or the Mann-Whitney U-test (PRISM 5.02). A P-value <0.05 was considered statistically significant.
Results

Analyses of residual pump blood and red blood cell concentrates
In 49 patients (96.1%), residual pump blood was retransfused (volume = 597 ± 141 ml per patient). Additionally, RBC concentrates were transfused in 25 patients (49.0%), with an average of 2.4 units per patient (see Table 1 ). In total, 49 units of residual pump blood and 58 units of RBC concentrates were transfused and analysed. The RBC concentrates were on average 11.2 ± 9.9 days old. All analysed parameters of the RBC concentrates met the expectations and fulfilled the standard requirements of RBC concentrates according to the operational procedures of the Department of Transfusion Medicine of the University Hospital Goettingen and the national guideline 10, 11 . Plasma free Hb was significantly higher in residual pump blood compared to RBC concentrates (0.99 ± 0.40 g/l versus 0.36 ± 0.21 g/l, P <0.0001, Table 1 ). Haemoglobin and haematocrit were significantly lower in residual pump blood compared to standard RBC concentrates (haemoglobin: 78 ± 26 g/l versus 185 ± 11 g/l; haematocrit: 0.22 ± 0.07 versus 0.56 ± 0.03). Mean platelet counts in residual pump blood were significantly higher compared to standard RBC concentrates (130 ± 63 versus <5 x 10 9 /l, P <0.0001). The mean pfHb in residual pump blood (0.99 ± 0.40 g/l) was nearly twice as high as the pfHb in patient blood taken contemporaneously (15 minutes after protamine administration) (0.5 ± 0.29 g/l) (P <0.0001, see Figure 1 ).
Patient characteristics and preoperative laboratory results
Preoperative baseline characteristics are presented in Table  2 . The mean values of preoperative blood cell counts were in the normal range. Intraoperative data, including the type of surgery, cross-clamp time, and CPB time, are also presented in Table 2 .
Perioperative course of plasma free haemoglobin, haemoglobin, and haematocrit in patients
The mean preoperative pfHb was 0.057 ± 0.06 g/l and showed a gradual increase to 0.54 ± 0.29 g/l 15 minutes after protamine administration and to 0.55 ± 0.36 g/l upon arrival in the ICU (see Figure 2 ). There was no significant difference in the pfHb concentration (15 minutes after protamine administration) between the centrifugal pump (median 0.5 g/l, IQR 0.43-0.61, n=43) and roller pump (median 0.44 g/l, IQR 0.34-0.57, n=8, P=0.409). On the first postoperative day, the patients' mean pfHb was 0.08 ± 0.02 g/l, almost within the normal range. The course of Hb and haematocrit in patient blood showed an approximately 30% drop in both Hb and haematocrit at the start of CPB.
Discussion
The objective of this study was to investigate the quality of residual pump blood with a focus on pfHb and blood cell counts, in order to contribute to the debate on whether re-transfusion of residual pump blood after cardiac surgery is an appropriate part of patient blood management.
With the re-transfusion of residual pump blood from the CPB circuit, any pfHb in the residual pump blood is also administered to the patient. Normally, pfHb is bonded to the plasma transport protein haptoglobin. This complex inhibits the oxidative activity of the pfHb 12 . However, once the transport capacity of haptoglobin is exceeded, pfHb levels rise in the plasma and pfHb is presented to the kidneys for excretion. Haemoglobinuria is one cause of acute kidney injury 1 , which occurs to some degree in 9%-39% of patients after cardiac surgery with CPB 13 . We found that the pfHb in patients' blood reached the maximum level upon arrival in the ICU. However, this level was almost the same at the previous measuring point 15 minutes after protamine administration, despite the administration of residual pump blood during the interval. Moreover, by the morning of the first postoperative day, patients' pfHb had returned to within the normal range.
In the present study, the mean pfHb in residual pump blood transfused to patients was 0.99 g/l (normal plasma concentration <0.1 g/l). Analysing the absolute values of pfHb, 0.6 g pfHb was transfused with a mean volume of 597 ml residual pump blood per patient. Figure 1 shows that the high pfHb of the residual pump blood was related to pfHb in the patients' blood before re-transfusion. The pfHb in patients was measured before re-transfusion (15 minutes after protamine administration) and then upon ICU arrival, when the re-transfusion was completed. Indeed, comparing the pfHb levels before and after re-transfusion revealed no difference, although a large quantity of the pfHb was re-transfused. Consequently, the infusion of residual pump blood did not alter the total patients' pfHb concentration. It is reasonable to assume that a certain quantity of the pfHb was rapidly excreted via the kidneys during this interval of approximately 45 minutes. This hypothesis can be supported by subsequent observations, where a 30% reduction of the pfHb concentration was found one hour after arrival in the ICU; by four hours, patients' pfHb had already reached a normal range.
Surprisingly, the mean pfHb in residual pump blood (0.99 ± 0.40 g/l) was nearly double that in patients' blood 15 minutes after protamine administration (0.54 ± 0.29 g/l) ( Figure 1) . This raises the question as to what happens to residual pump blood to increase pfHb levels before it is drained into transfusion bags and re-transfused. With the administration of protamine, blood aspiration by pump suckers into the CPB reservoir is ceased. The sharp increase in pfHb in residual pump blood could be explained by the CPB centrifuge continuing to run, thereby continuously injuring the erythrocytes. The earliest possible timepoint of filling the residual pump blood bags is therefore of great importance and should be considered carefully by the surgical team. Another reason is that the cross-section of the tubes for the circulating residual blood within the circuit post CPB is smaller, and this may contribute to further damage of the blood cells. This could be reduced by disconnecting the small shunt tubes as soon as they are no longer needed. Finally, a slow filling of the residual pump blood bag may prevent exposing the blood cells to unnecessary further trauma.
Another option is to process the residual pump blood by washing it using a cell salvage device to clear it of plasma, pfHb, and inflammatory mediators before re-transfusion. However, there is controversy regarding the impact on blood quality after using a cell salvage device to wash residual pump blood before re-transfusion. Previous studies have found that patients who received unprocessed blood had a higher volume of postoperative blood loss and needed a higher number of units of allogenic RBC concentrates compared to patients who received residual pump blood processed with a cell salvage device 14 . Other studies have found that the re-transfusion of processed pump blood was more effective in increasing haematocrit and postoperative haemoglobin and in reducing the need for donor blood transfusions compared to unprocessed pump blood 15, 16 . Furthermore, a lower rate of infective complications and length of hospital stay compared to patients who received unprocessed pump blood and no pump blood has been observed 15 . In 2007, a guideline was published which recommended the routine use of a cell-saving device in cardiac surgery 17 . On the other hand, cell salvage has been reported to induce strong thrombin generation and fibrinolysis activation, and to lower fibrinolysis inhibition, which could generate a consumption coagulopathy 16 . More recently, Iyer and colleagues reported no deleterious effects on the coagulation system after re-transfusion of unprocessed residual pump blood. They observed an increase in fibrinogen, haemoglobin and platelet count in the patients' blood after re-transfusion of unprocessed residual pump blood 18 . Another trial showed that cell salvage of the residual pump blood reduced platelet numbers, prolonged the clot formation time and reduced clot firmness 19 .
Haemoglobin and haematocrit levels in residual pump blood were less than half of those in standard RBC concentrates. RBC concentrates contain almost no platelets as standard, whereas the platelet count in residual pump blood was in the range of the patients' blood. In the event of postoperative bleeding, the focus is both on maintaining an adequate haemoglobin level and on keeping coagulation factors and the platelet count in a target range. In our study, the mean platelet count in residual pump blood was 130 x 10 9 /l (standard RBC concentrates contain <5 x 10 9 /l). Regarding the functionality of platelets in residual pump blood after CPB, it seems probable that the residual function of these platelets is lowered but is likely to still assist in blood coagulation. Therefore, an additional administration of allogenic platelets might be prevented, which may be of benefit, especially as platelet transfusion is also a risk factor for morbidity and mortality after cardiac surgery 20, 21 . In addition, allogenic platelets lose 25% of their aggregation function after one day of storage and 40% of their function after five days of storage 22 .
Another concern with the administration of residual pump blood is an increased risk of postoperative bleeding due to residual heparin 23 . However, heparin in residual pump blood can be antagonised with additional protamine, and should not affect coagulation. Duara and colleagues reported that postoperative drainage was not increased after re-transfusion, so they recommend the use of residual pump blood in the immediate postoperative period rather than discarding it 23 . 
Limitations of the study
This study has several limitations as it was conducted as a small observational study without intervention, and we did not compare patients who received residual pump blood and those who did not. As the re-transfusion of residual pump blood is a standard procedure in our institution, we did not compare an intervention and control group. For this reason, our findings should be interpreted with caution.
Conclusions
At the end of cardiac surgery involving CPB, one of the reasons that cardiac surgeons and anaesthetists may wish to avoid the re-transfusion of residual pump blood is the pfHb load in the residual pump blood. Our data show that the pfHb in residual pump blood, although markedly higher than the levels in both patients' blood and RBC concentrates, did not cause a significant increase in patients' pfHb levels after re-transfusion. We believe that the re-transfusion of residual pump blood after cardiac surgery should not be withheld on the basis of high pfHb levels in residual pump blood alone.
